2015 Press Releases 2024 2023 2022 2021 2020 Portfolio Companies New Leaf Portfolio Companies Versartis’ VRS-317 6-Month Data Published in The Journal of Clinical Endocrinology & Metabolism December 16, 2015 Afferent Pharmaceuticals Advances Novel Molecule, AF-130, to Phase 1 Clinical Trial December 8, 2015 True North Therapeutics Announces $40 Million Series C Financing December 3, 2015 QPID Health to Showcase New Approach to Quality Reporting at the IHI Forum on Quality Improvement in Healthcare December 1, 2015 Acelity Acquires SNaP® Disposable Negative Pressure Wound Therapy System to Expand Offering in Portable, Non-Powered NPWT Technology December 1, 2015 iRhythm Technologies Launches New iOS App Enabling Patients to Report Irregular Heartbeat Symptoms for Physician Diagnosis November 18, 2015 WAVE Life Sciences Announces Pricing of Initial Public Offering November 11, 2015 TigerText Closes on $50 Million in Financing to Accelerate Growth; Launches TigerText Anywhere Initiative November 11, 2015 ReShape Medical, Inc. Builds Momentum with Next Generation Integrated Dual Balloon System at ObesityWeek 2015 November 2, 2015 KLAS Report Names TigerText Most Widely Adopted Solution For Secure Messaging October 28, 2015 Arvinas Secures $41.6M Series B Financing – Appoints New Board Members October 21, 2015 Relypsa announces FDA approval of Veltassa (TM) (Patiromer) for oral suspension for the treatment of Hyperkalemia October 21, 2015 Dimension Therapeutics Announces Pricing of Initial Public Offering October 21, 2015 Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer October 21, 2015 Kit Check Adds Children’s Hospital of Orange County as 200th Hospital Customer October 21, 2015 QPID Health Announces Groupers for Epic October 20, 2015 U.S. News & World Report and Kyruus Team Up to Help Patients Book Doctor Appointments October 19, 2015 Edge Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option October 6, 2015 Versartis Presents Confirmatory 18-Month Data From Ongoing Somavaratan Extension Study at Late-Breaker Session at ESPE Annual Meeting October 1, 2015 Afferent Pharmaceuticals Announces Positive Results in Phase 2b Chronic Cough Trial September 21, 2015 Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline September 21, 2015 Sharp HealthCare Selects QPID Health for PQRS Compliance September 21, 2015 Versartis Announces Confirmatory 18-Month Data From Ongoing Extension Study of Somavaratan in GHD Children September 18, 2015 Dimension Therapeutics Announces FDA Fast Track Designation for Lead Candidate DTX101 in Patients with Hemophilia September 17, 2015 Kyruus Raises $25 million to Accelerate Market Adoption of Its Patient Access Platform for Hospital Systems September 17, 2015 Intarcia Presents Results from Two Successful Phase 3 Trials for ITCA 650, Its Investigational Therapy in Type 2 Diabetes, at 51st EASD September 16, 2015 Versartis Initiates Phase 2 Trial (VITAL) of Monthly Somavaratan in Adults With Growth Hormone Deficiency September 10, 2015 Holyoke Medical Center Selects QPID Health for Quality Initiative September 2, 2015 ReShape Medical, Inc. Completes $38 Million Series D Financing August 26, 2015 Edge Therapeutics Reports Positive Top-Line Phase 1/2 NEWTON Trial Results of EG-1962 in Aneurysmal Subarachnoid Hemorrhage August 19, 2015 Intarcia Announces New Top-Line Phase 3 Results for Investigational Therapy ITCA 650 in Type 2 Diabetes: Freedom-2 Comparative Trial Demonstrates Superior & Sustained Glucose Control and Weight Reduction vs Januvia Over 52 Weeks August 18, 2015 WAVE Life Sciences Raises $66 Million in Series B Financing August 18, 2015 QPID Health to Deploy at Providence Health & Services August 11, 2015 Relypsa Enters Two-Year Detailing Agreement With Sanofi in the United States August 10, 2015 New App Helps Consumers Find More Ways to Save on Prescription Drugs August 5, 2015 FDA Approves The ReShape™ Integrated Dual Balloon System, a First-Of-Its-Kind Non-Surgical Weight Loss Procedure for People with Mild to Moderate Obesity July 28, 2015 Chimerix Announces Positive Topline Results From Brincidofovir Pivotal Study in Animal Model for Smallpox July 23, 2015 QPID Health sequences the “digital DNA” in your health record July 22, 2015 Afferent Pharmaceuticals Raises $55 Million in Oversubscribed Crossover Financing July 8, 2015 Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing June 18, 2015 Tioga Pharmaceuticals Announces Initiation of Phase 2 Clinical Study of Asimadoline in Patients with Pruritus Associated with Atopic Dermatitis June 11, 2015 Unum Therapeutics Announces $65 Million Series B Financing Round June 11, 2015 Oxford Immunotec Announces First Patient Enrolled in REACT Trial for T-SPOT.CMV June 11, 2015 Intarcia’s Kurt Graves Named an EY Entrepreneur Of The Year® 2015 June 5, 2015 VaxInnate Advances Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, into Phase 2 Study June 3, 2015 Spiracur Expands Global Reach with the Release of New International Clinical Data and the Introduction of the SNaP Plus Therapy System June 2, 2015 Edge Therapeutics Completes Enrollment in Phase 1/2 NEWTON Study of EG-1962 for Patients with Ruptured Brain Aneurysm May 28, 2015 Kit Check Tracks Five Million Hospital Medications with RFID and Cloud Software Solution May 28, 2015 Oxford Immunotec Announces CE Mark Approval for T-SPOT.CMV Test April 27, 2015 Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing with Equity Conversion Option at $5.5 Billion Valuation April 27, 2015 Neuronetics Closes $34 Million in Series F Financing with GE Ventures and Current Investors April 27, 2015 Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring April 21, 2015 Dimension Therapeutics Secures $65 Million in Oversubscribed Series B Financing April 21, 2015 TigerText Introduces First Secure Enterprise Messaging App for the Apple Watch April 14, 2015 Versartis Initiates Phase 2/3 Trial of VRS-317 in Japan for Children With Growth Hormone Deficiency April 13, 2015 Karyopharm Granted U.S. Composition-of-Matter Patent for Selinexor (KPT-330) April 13, 2015 Edge Therapeutics Raises $72.5 Million Through Successive Series C-1 and C-2 Financings April 9, 2015 Group Message Confirmations Are Here! (TigerText) April 9, 2015 Amerinet Offers Kit Check to 3,000 Member Hospitals April 7, 2015 Oxford Immunotec Announces Availability of the T-SPOT.CMV Test in the United States March 31, 2015 CardioKinetix Announces Excellent Results of Chinese Trial Evaluating Parachute Heart Failure Device March 24, 2015 Intarcia and Numab Sign Multi-Asset Collaboration to Develop Once-Yearly Therapies in Diabetes, Obesity, and Autoimmune Indications March 19, 2015 Truveris Launches Pharmacy Stop Loss Insurance Platform to Protect Employers from Rising Benefit Costs March 17, 2015 Relypsa Announces Phase 2 Data Showing Efficacy of Patiromer FOS in Heart Failure Patients With Chronic Kidney Disease at ACC Scientific Session March 14, 2015 TigerText Launches TigerConnect Secure Messaging Platform March 3, 2015 VaxInnate Receives Extension of Contract from BARDA for Development of Seasonal and Pandemic Influenza Vaccines February 17, 2015 Oxford Immunotec Global PLC Announces Pricing of Underwritten Offering of Ordinary Shares January 30, 2015 Versartis Announces Pricing of Follow-On Offering January 21, 2015 Kit Check Raises $12 Million Series B January 12, 2015 Chimerix Receives Notice of Allowance for Brincidofovir Composition of Matter Patent Extending Exclusivity to 2034 January 12, 2015 Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals January 11, 2015 Oxford Immunotec Announces Completion of Re-Registration in China for T-SPOT.TB Test January 6, 2015 Relypsa Announces Assignment of October 21, 2015 PDUFA Date for New Drug Application for Patiromer for Oral Suspension January 5, 2015 Versartis Announces Positive 12 Month Data for VRS-317 from Ongoing Extension Study January 5, 2015